Erectile dysfunction and diabetes: a study in primary care

Abstract

This study set out to determine whether there has been an increase in awareness of ED amongst men with diabetes following the introduction of oral therapy and whether there is an association between ED and QoL. Current perceptions of 157 men with diabetes were compared with the results of a 1997 survey. Those who reported ED (66/157) completed a questionnaire assessing the impact of ED on QoL. Patients are more aware of ED now than in 1997; more treatments are now offered in primary care. The results demonstrated a weak, but significant, association between awareness of therapy (represented by the number of treatments of which patients were aware) and QoL. Patients who were aware of treatments had a significantly worse QoL than those who were unaware.

Keywords

diabetes mellitus erectile dysfunction primary care cardiovascular disease quality of life.

Get full access to this article

View all access options for this article.

References

Price D. , Gingell J. , Gepi- Attee S. , Wareham K. , Yates P. , Boolell M. Sildenafil: Study of a Novel Oral Treatment for Erectile Dysfunction in Diabetic Men. Diabet Med 1998;15:821-5.

Gilbert R. Sexual Dysfunction in the Male. In: Gilbert R, editor. Management of ED: Focus on Sildenafil Citrate. A Diabetologist's/ Endocrinologist's Approach. Quebec: PharmaLibri Publishers, Inc, 1999.

Ali W. , Besarani D. , Kirby R. Modern treatment of erectile dysfunction. Br J Diab Vasc Dis 2002;2:255-61.

Heaton J. , Morales A. , Adams M. Erectile Dysfunction In: Gerstein H , Haynes R , editors. Evidence-Based Diabetes Care. London: BC Decker Inc, 2001:531-44.

McCulloch DK , Campbell IW , Wu FC , Prescott RJ , Clarke BF The prevalence of diabetic impotence. Diabetologia 1980;18:279-83.

Price D. , O'Malley B. , James M. , Roshan M. , Hearnshaw J.

Why are impotent diabetic men not being treated?

Pract Diab 1991;8(1):10-11.

Marks LS , Duda C. , Dorey FJ , Macairan ML , Santos PB Treatment of erectile dysfunction with sildenafil. Urology 1999;53(1):19-24.

Government WA National Service Framework for Diabetes in Wales: Delivery Strategy: Health Services Policy and Development, 2003.

BMA. www.bma.org.uk/ap.nsf/content/Hubthenewgmscontract Accessed 5th November, 2004.

10.

Kirby M. ED as a marker for cardiovascular disease. Br J Diab Vasc Dis 2002;2:239-41.

11.

Jackson G. , Betteridge J. , Dean J. et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract 1999;53:445-51.

12.

Cummings M. , Meeking D. , Warburton F. , Alexander W. The diabetic male's perception of erectile dysfunction. Practical Diabetes International 1997;14(4):100-02.

13.

MacDonagh R. , Ewings P. , Porter T. The effect of erectile dysfunction on quality of life: psychometric testing of a new quality of life measure for patients with erectile dysfunction. J Urol 2002;167:212-17.

14.

Lyons R. , Wareham K. , Lucas M. , Price D. , Williams J. , Hutchings HA SF-36 scores vary by method of administration: implications for study design . J Pub Health Med 1999;21:41-5.

15.

Rance J. , Phillips C. , Davies S. , O'Malley B. , Zaman Q. , Price D. How much of a priority is treating erectile dysfunction? A study of patients' perceptions. Diabet Med 2003;20:205-09.

16.

Price D. How should erectile dysfunction in diabetes be managed? In: Gill G , Pickup J , Williams G , editors. Difficult Diabetes. Oxford: Blackwell Science, 2001:285-27.

17.

Snow KJ Erectile dysfunction in patients with diabetes mellitus- advances in treatment with phosphodiesterase type 5 inhibitors. Diab Vasc Dis 2002;2:282-7.

18.

Sadovsky R. , Mulhall JP The Potential Value of Erectile Dysfunction Inquiry and Management. IJCP 2003 ;57:601-08.

19.

Jackson G. Erectile Dysfunction: a management algorithm. Int J Clin Prac 2004;58:733-4.